Activation of the Arp2/3 complex is regulated by multiple phospho-modification, and multiple regulator, including PCK1, PIK4, and NIK, which can phosphorylate the Arp2/3 complex, are potential targets against cancer invasion. Here, ACTR2 is linked to cancer.